GH
Price
$47.34
Change
+$1.70 (+3.72%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.46B
5 days until earnings call
GKOS
Price
$95.41
Change
+$2.80 (+3.02%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
4.61B
5 days until earnings call
Ad is loading...

GH vs GKOS

Header iconGH vs GKOS Comparison
Open Charts GH vs GKOSBanner chart's image
Guardant Health
Price$47.34
Change+$1.70 (+3.72%)
Volume$44.67K
Capitalization2.46B
Glaukos
Price$95.41
Change+$2.80 (+3.02%)
Volume$7.34K
Capitalization4.61B
GH vs GKOS Comparison Chart
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. GKOS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a StrongBuy and GKOS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GH: $47.41 vs. GKOS: $92.61)
Brand notoriety: GH: Notable vs. GKOS: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 80% vs. GKOS: 83%
Market capitalization -- GH: $2.46B vs. GKOS: $4.61B
GH [@Medical Specialties] is valued at $2.46B. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while GKOS’s TA Score has 6 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 3 bearish.
  • GKOS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than GH.

Price Growth

GH (@Medical Specialties) experienced а +5.43% price change this week, while GKOS (@Medical Specialties) price change was +4.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

GH is expected to report earnings on Jul 31, 2025.

GKOS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than GH($2.47B). GH YTD gains are higher at: 55.188 vs. GKOS (-38.235). GKOS has higher annual earnings (EBITDA): -82.12M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. GKOS (295M). GKOS has less debt than GH: GKOS (384M) vs GH (1.35B). GH has higher revenues than GKOS: GH (564M) vs GKOS (315M).
GHGKOSGH / GKOS
Capitalization2.47B4.61B54%
EBITDA-433.3M-82.12M528%
Gain YTD55.188-38.235-144%
P/E RatioN/AN/A-
Revenue564M315M179%
Total Cash1.17B295M396%
Total Debt1.35B384M353%
FUNDAMENTALS RATINGS
GH vs GKOS: Fundamental Ratings
GH
GKOS
OUTLOOK RATING
1..100
638
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10046
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
3685
P/E GROWTH RATING
1..100
10051
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (67) in the Medical Or Nursing Services industry is in the same range as GKOS (93) in the Medical Specialties industry. This means that GH’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (46) in the Medical Specialties industry is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew somewhat faster than GH’s over the last 12 months.

GKOS's SMR Rating (92) in the Medical Specialties industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for GKOS (85) in the Medical Specialties industry. This means that GH’s stock grew somewhat faster than GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew somewhat faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHGKOS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 17 days ago
67%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OOTO12.500.59
+4.91%
Direxion Daily Travel & Vctn Bll 2X ETF
WTAI18.460.67
+3.77%
WisdomTree Artfcl Intllgnc & Innvtn ETF
RSPC33.790.39
+1.18%
Invesco S&P 500® Eql Wght Comm Svcs ETF
FALN26.020.16
+0.62%
iShares Fallen Angels USD Bond ETF
BTAL20.60-0.42
-2.00%
AGF U.S. Market Neutral Anti-Beta

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with RDNT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+3.21%
RDNT - GKOS
50%
Loosely correlated
+1.74%
ISRG - GKOS
50%
Loosely correlated
+1.92%
NTRA - GKOS
49%
Loosely correlated
+2.72%
ALGN - GKOS
47%
Loosely correlated
+1.93%
ITGR - GKOS
46%
Loosely correlated
+2.14%
More